Pediatric Antibiotic Dosing in Extracorporal Membrane Oxygenation (PADECMO)

NARecruitingINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 19, 2016

Primary Completion Date

December 1, 2025

Study Completion Date

July 1, 2026

Conditions
PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactamMeropenemCefazolinTeicoplaninVancomycinCiprofloxacinAmikacin
Interventions
OTHER

Amoxicillin-clavulanate

blood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical care

OTHER

Piperacillin-tazobactam

blood sampling in patients receiving piperacillin-tazobactam as part of routine clinical care.

OTHER

Meropenem

blood sampling in patients receiving meropenem as part of routine clinical care.

OTHER

Cefazolin

blood sampling in patients receiving cefazolin as part of routine clinical care.

OTHER

Vancomycin

blood sampling in patients receiving vancomycin as part of routine clinical care.

OTHER

Teicoplanin

blood sampling in patients receiving teicoplanin as part of routine clinical care.

OTHER

Ciprofloxacin

blood sampling and urine sampling in patients receiving ciprofloxacin as part of routine clinical care.

OTHER

Amikacin

blood sampling in patients receiving amikacin as part of routine clinical care.

Trial Locations (3)

1020

RECRUITING

Queen Fabiola Children's University Hospital, Brussels

3000

RECRUITING

Universitair hospital, Leuven

9000

RECRUITING

University Hospital, Ghent

All Listed Sponsors
lead

University Hospital, Ghent

OTHER